OTCPK:SHPHF (China)
Â
$
0.049
-0.043 (-46.52%)
07:08 PM EST
What is a stock summary page? Click here for an overview.
Business Description
Sihuan Pharmaceutical Holdings Group Ltd
NAICS : 325414
ISIN : BMG8162K1137
Compare
Compare
Traded in other countries / regions
00460.Hong KongTEL1.GermanySHPHF.USA IPO Date
2011-11-14Description
Sihuan Pharmaceutical Holdings Group Ltd is an investment holding company. Along with its subsidiaries, the company is engaged in the research & development and the manufacture & sale of pharmaceutical products. Its portfolio comprises products for diseases related to the cardio-cerebral vascular (CCV) system, Respiratory, Neurology, and others. The group has three reportable segments: the medical aesthetic products segment including the filling, shaping, supporting, supplementing, optoelectronic device, body sculpturing, skincare, and others; the innovative medicine and other medicine segments; and the generic medicine segment which generates key revenue. Geographically, the company generates a majority of its revenue from Mainland China and the rest from the United States.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 4.31 | |||||
| Equity-to-Asset | 0.38 | |||||
| Debt-to-Equity | 0.26 | |||||
| Debt-to-EBITDA | 3.22 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 1.01 | |||||
| Beneish M-Score | -2.63 | |||||
| WACC vs ROIC | ||||||
Growth Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.8 | |||||
| 3-Year EBITDA Growth Rate | -33.4 | |||||
| 3-Year FCF Growth Rate | 37 | |||||
| 3-Year Book Growth Rate | -23.3 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 9-Day RSI | 0.35 | |||||
| 14-Day RSI | 2.43 | |||||
| 6-1 Month Momentum % | -24.31 | |||||
| 12-1 Month Momentum % | 9.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.64 | |||||
| Quick Ratio | 1.52 | |||||
| Cash Ratio | 1.18 | |||||
| Days Inventory | 336.75 | |||||
| Days Sales Outstanding | 85.99 | |||||
| Days Payable | 124.44 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Dividend Growth Rate | 32.2 | |||||
| 3-Year Average Share Buyback Ratio | 0.5 | |||||
| Shareholder Yield % | 6.45 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 65.93 | |||||
| Operating Margin % | -15.2 | |||||
| Net Margin % | -2.14 | |||||
| FCF Margin % | -2.24 | |||||
| ROE % | -0.85 | |||||
| ROA % | -0.32 | |||||
| ROIC % | -5.13 | |||||
| 3-Year ROIIC % | 81.51 | |||||
| ROC (Joel Greenblatt) % | 4.2 | |||||
| ROCE % | 1.47 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shiller PE Ratio | 9.08 | |||||
| PS Ratio | 2.98 | |||||
| PB Ratio | 1.19 | |||||
| Price-to-Tangible-Book | 1.64 | |||||
| Price-to-Operating-Cash-Flow | 25.42 | |||||
| EV-to-EBIT | 18.33 | |||||
| EV-to-EBITDA | 6.34 | |||||
| EV-to-Revenue | 1.25 | |||||
| EV-to-FCF | -56.06 | |||||
| Price-to-GF-Value | 0.98 | |||||
| Price-to-Projected-FCF | 0.7 | |||||
| Price-to-Median-PS-Value | 0.55 | |||||
| Earnings Yield (Greenblatt) % | 5.46 | |||||
| FCF Yield % | -0.75 | |||||
| Forward Rate of Return (Yacktman) % | 23.88 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:SHPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Sihuan Pharmaceutical Holdings Group Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 243.627 | ||
| EPS (TTM) ($) | -0.001 | ||
| Beta | -0.49 | ||
| 3-Year Sharpe Ratio | -0.48 | ||
| 3-Year Sortino Ratio | -0.6 | ||
| Volatility % | 85.89 | ||
| 14-Day RSI | 2.43 | ||
| 14-Day ATR ($) | 0.000034 | ||
| 20-Day SMA ($) | 0.0492 | ||
| 12-1 Month Momentum % | 9.33 | ||
| 52-Week Range ($) | 0.045 - 0.095 | ||
| Shares Outstanding (Mil) | 9,300 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Sihuan Pharmaceutical Holdings Group Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Sihuan Pharmaceutical Holdings Group Ltd Frequently Asked Questions
What is Sihuan Pharmaceutical Holdings Group Ltd(SHPHF)'s stock price today?
The current price of SHPHF is $0.05. The 52 week high of SHPHF is $0.10 and 52 week low is $0.05.
When is next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(SHPHF)?
The next earnings date of Sihuan Pharmaceutical Holdings Group Ltd(SHPHF) is 2025-08-29 Est..
Does Sihuan Pharmaceutical Holdings Group Ltd(SHPHF) pay dividends? If so, how much?
Sihuan Pharmaceutical Holdings Group Ltd(SHPHF) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers